Process Development
including Pilot Filling Capabilities
The ability to move development stage products into First in Man clinical studies is now a key step in accelerating the development process. To better serve these client needs, Exemplar provides state of the art cGMP compliant, Class 100,000 manufacturing suites for pMDIs, DPIs, nasal and buccal sprays in support of Phase I through Phase IV activities. All processes are carried out in controlled environments.